A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 6922-6928

  Reimann, Keith A ^a,b   Li, John T ^a   Veazey, Ronald ^a   Halloran, Matilda ^a   Park, In Woo ^a   Karlsson, Gunilla B ^a   Sodroski, Joseph ^a   Letvin, Norman L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHIMERA; CONTROLLED STUDY; ENVELOPE GENE; GENETIC POLYMORPHISM; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONKEY DISEASE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0029794529     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.6922-6928.1996     Document Type: Article

References (22)

1. Cheng-Mayer, C., M. Quiroga, J. W. Tung, D. Dina, and J. A. Levy. 1990. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J. Virol. 64:4390-4398.
2. Collman, R., J. W. Balliet, S. A. Gregory, H. Friedman, D. L. Kelson, N. Nathanson, and A. Srinivasan. 1992. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66:7517-7521.
3. Daar, E. S., X. L. Li, T. Moudgil, and D. D. Ho. 1990. High concentrations of recombinant soluble CD4 are required to neutralize primary HIV-1 isolates. Proc. Natl. Acad. Sci. USA 87:6574-6578.
4. Fultz, P. N., H. M. McClure, D. C. Anderson, and W. M. Switzer. 1989. Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res. Hum. Retroviruses 5:397-409.
5. Javaherian, K., A. J. Langlois, S. Schmidt, M. Kaufmann, N. Cates, J. P. Langedijk, R. H. Meloen, R. C. Desrosiers, D. P. Burns, D. P. Bolognesi, et al. 1992. The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89:1418-1422.
6. Kanki, P. J., M. F. McLane, N. W. King, Jr., N. L. Letvin, R. D. Hunt, P. Sehgal, M. D. Daniel, R. C. Desrosiers, and M. Essex. 1985. Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science 228:1199-1201.
7. Lackner, A. A. 1994. Pathology of simian immunodeficiency virus induced disease. Curr. Top. Microbiol. Immunol. 188:35-64.
8. Letvin, N. L. 1992. Animal models for the study of human immunodeficiency virus infections. Curr. Opin. Immunol. 4:481-485.
9. Li, J. T., M. Halloran, C. I. Lord, A. Watson, J. Ranchalis, M. Fung, N. L. Letvin, and J. G. Sodroski. 1995. Persistent infection of macaques with simian-human immunodeficiency viruses. J. Virol. 69:7061-7071.
10. mac virus that expresses the HIV-1 envelope glycoprotein. J. Acquired Immune Defic. Syndr. 5:639-646.
11. Luciw, P. A., E. Pratt-Lowe, K. E. S. Shaw, J. A. Levy, and C. Cheng-Mayer. 1995. Persistent infection of rhesus macaques with T cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc. Natl. Acad. Sci. USA 92:7490-7494.
12. Meyers, G., B. Korber, S. Wain-Hobson, and R. F. Smith (ed.). 1993. Human retroviruses and AIDS 1993. Los Alamos National Laboratory, Los Alamos, N.Mex.
13. Murphy-Corb, M., L. N. Martin, S. R. S. Rangan, G. B. Baskin, B. J. Gormus, R. H. Wolf, W. A. Andes, M. West, and R. C. Montelaro. 1986. Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature (London) 321:435-438.
14. National Institutes of Health. 1985, Guide for the care and use of laboratory animals, revised ed. Department of Health and Human Services publication no. (NIH) 85-23. National Institutes of Health, Bethesda, Md.
15. Pachl, C., J. A. Todd, D. G. Kern, P. J. Sheridan, S. J. Fong, M. Stempien, B. Hoo, D. Besemer, T. Yeghiazarian, B. Irvine, J. Kolberg, R. Kokka, P. Neuwald, and M. S. Urdea. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J. Acquired Immune Defic. Syndr. 8:446-454.
16. Park, I.-W., and J. Sodroski. 1995. Amino acid sequence requirements for the incorporation of the Vpx protein of simian immunodeficiency virus into virion particles. J. Acquired Immune Defic. Syndr. 10:506-510.
17. Reimann, K. A., J. T. Li, G. Voss, C. Lekutis, K. Tenner-Racz, P. Racz, W. Lin, D. C. Montefiori, D. E. Lee-Parritz, Y. Lu, R. G. Collman, J. Sodroski, and N. L. Letvin. 1996. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 70:3198-3206.
18. Reimann, K. A., B. C. D. Waite. D. E. Lee-Parritz, W. Lin, B. Uchanska-Ziegler, M. J. O'Connell, and N. L. Letvin. 1994. Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys. Cytometry 17:102-108.
19. Ringler, D. J., R. D. Hunt, R. C. Desrosiers, M. D. Daniel, L. V. Chalifoux, and N. W. King. 1988. Simian immunodeficiency virus-induced meningoencephalitis: natural history and retrospective study. Ann. Neurol. 23(Suppl.): S101-S107.
20. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1991. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature (London) 349:167-169.
21. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
22. Thali, M., U. Olshevsky, C. Furman, D. Gaburzda, M. Posner, and J. Sodroski. 1991. Characterization of a discontinuous HIV-1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J. Virol. 65:6188-6193.